Should we be using prehospital antiarrhythmics anymore?
The ALPS study seems like very good evidence against stocking extra unnecessary prehospital medications such as amid and lidocaine. My agency still has both on formulary and we probably spend more money are replacing expired meds than we do on preventing recurrent v-fib.
What are other’s thoughts on the AHA recommendations for the 300 then 150 of amiodirone or use of lidocaine for refractory VF? http://www.nejm.org/doi/full/10.1056/NEJMoa1514204